about
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a ...
Read More
3.34
-0.10
(-2.91%)
2.6M
XNAS Volume
XNAS 07 May, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Replimune Grp Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..